Induction of tumor necrosis factor-α in vivo by a skin irritant, tributyltin, through activation of transcription factors: Its pharmacological modulation by anti-inflammatory drugs

Journal of Investigative Dermatology

Volumn 108, Issue 6, 1997, Pages 892-896

  Corsini, Emanuela ^a   Terzoli, Alessandra ^a   Bruccoleri, Alessandra ^a   Marinovich, Marina ^a   Galli, Corrado Lodovico ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

NF B; Organotin; Skin irritation

Indexed keywords

ACETONE; ANTIINFLAMMATORY AGENT; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRRITANT AGENT; MESSENGER RNA; PENTAMIDINE ISETHIONATE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRANSCRIPTION FACTOR; TRIBUTYLTIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL NUCLEUS; CELL STRAIN L 929; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; FEMALE; GENE EXPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; MEDIATOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION; TRANSACTIVATION; TRANSCRIPTION INITIATION;

EID: 0031005135     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12292696     Document Type: Article

References (32)

1. Adcock IM, Shirasaki H, Gelder CM, Peters MJ, Brown CR, Barnes PJ: The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung. Life Sci 55:147-153, 1994
2. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179, 1994
3. Blaylock BL, Kouchi Y, Comment CE, Corsini E, Rusenthal GJ, Luster MI: Pentamidine isethionate reduces Ia expression and antigen presentation by Langerhans cells and inhibits the contact hypersensitivity reaction. J Immunol 147:2116-2121, 1991
4. Boss JD, Kapsenberg ML: The skin immune system; progress in cutaneous biology. Immunol Today 14:75-78, 1993
5. Corsini E, Bruccoleri A, Marinovich M, Galli CL: Endogenous interleukin-1α is associated with skin irritation induced by tributyltin. Toxicol Appl Pharmacol 138:268-274, 1996a
6. Corsini E, Craig WA, Rosenthal GJ: Modulation of tumor necrosis factor release from alveolar macrophages treated with pentamidine isethionate. Int J Immunopharmacol 14:121-130, 1992
7. Corsini E, Schubert C, Marinovich M, Galli CL.: Role of mitochondria in tributyltininduced interleukin-1α production in murine keratinocytes. J Invest Dermatol 107:720-725, 1996b
8. Enk HA, Katz SI: Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89:1398-1402, 1992
9. Gordon JR, Galli SJ: Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 346:274-276, 1990
10. Groves RW, Allen MH, Ross EL, Barker JNWN, Macdonald DM: Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol 132:345-352, 1995
11. Kock A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, Luger TA: Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172:1609-1614, 1990
12. Kupper TS: Immune and inflammatory process in cutaneous tissues. Mechanisms and speculations. J Clin Invest 86:1783-1789, 1990
13. Kupper TS: Mechanism of cutaneous inflammation, Interaction between epidermal cytokines, adhesion molecules and leukocytes. Arch Dermatol 125:1406-1412, 1989
14. Larrick JW, Morhenn V, Chiang YL, Shi T: Activated Langerhans cells release tumor necrosis factor. J Leukoc Biol 45:429-433, 1989
15. Marinovich M, Viviani B, Galli CL; Reversibility of TBT-induced protein synthesis inhibition after ATP recovery in HEL30 cells. Toxicol Lett 52:311-317, 1990
16. Middleton MC: Early metabolic changes in rat epidermal and dermis following cutaneous application of irritant doses of tributyltin. J Invest Dermatol 79:163-166, 1982
17. Middleton MC, Pratt I: Skin water content as a quantitative index of the vascular and histologic changes produced in rat skin by di-n-butyltin and tri-n-butyltin. J Invest Dermatol 68:379-384, 1977
18. Muegge K, Durum SK: Cytokines and transcription factors. Cytokine 2:1-8, 1990
19. Nickoloff BJ, Griffith CEM, Barker JNWN: The role of adhesion molecules, chemotactic factors and cytokines in inflammatory and neoplastic skin diseases-1990 update. J Invest Dermatol 94:1515-1575, 1990
20. Piguet PF, Grau GE, Allet B, Vassalli P: Tumor necrosis factor/cachectin is an effector of skin and gut lesions of acute phase of graft-vs-host disease. J Exp Med 166:1280-1289, 1987
21. Piguet PF, Grau GE, Houser C, Vassalli P: Tumor necrosis factor is a critical mediators in hapten-induced irritant and contact hypersensitivity reactions. J Exp Med 173:673-679, 1991
22. Pober JS, Contran RS: Cytokines and endothelial cell biology. Physiol Rev 70:427-451, 1990
23. Rhoades KL, Golub SH, Economou JS: The regulation of the human tumor necrosis factor α promoter region in macrophage, T cell, and B cell lines. J Biol Ghem 31:22102-22107, 1992
24. Rosenthal GJ, Corsini E: Tumor necrosis factor-α in immunotoxicity assessment. In: Burlenson, Dean, Munson (eds.) Methods in Immunology. Vol I, pp 327-343, Wiley Liss, New York, 1995
25. Rosenthal GJ, Corsini E, Craig WA, Comment CE, Luster MI: Pentamidine: an inhibitor of interleukin-1 that acts via a post-translational event. Toxicol Appl Pharmacol 107:555-561, 1991
26. Rosenthal GJ, Craig WA, Corsini E, Taylor M, Luster M.: Pentamidine blocks the pathophysiologic effects of endotoxemia through inhibition of cytokine release. Toxicol Appl Pharmacol 112:222-228, 1992
27. Sands M, Kron MA, Brown RB: Pentamidine: a review. Rev Infect Dis 7:625-634, 1985
28. Schule R, Rangarajah P, Kliewer S, Ransone LJ, Bolado J, Yang IM, Verna IM, Evans RM: Functional antagonism between oncoprotehi c-jun and the glucocorticoid receptor. Cell 62:1217-1226, 1990
29. Shakov AN, Collart MA, Vassalli P, Nedospasov SA, Nongeneel CV: Kappa B-type enhancer are involved in lipopolysaccharide-mediated transcriptional acrivation of the tumor necrosis factor alpha gene in primary macrophages. J llxp Med 171:35-47, 1990
30. Siioeij NJ, Penninks AH, Seinen W: Biological activity of organotin compounds-an overview. Environ Res 44:335-53, 1987
31. Wakefield PE, James WD, Samlaska CP, Mettzes MS: Tumor necrosis factor. J Am Afad Drrmatol 24:675-685, 1991
32. World Health Organization: Tributyltin compounds. Environmental Health Criteria 116. WHO, Geneva, 1990